The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.25
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (7.143%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 7.25
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report & Disposal

2 Nov 2015 14:35

RNS Number : 2426E
Braveheart Investment Group plc
02 November 2015
 

 

 

2 November 2015

Braveheart Investment Group plc

('Braveheart', the 'Company' or the 'Group')

 

Half-Yearly Report and Disposal of interest in Investee Company

 

Braveheart Investment Group plc today announces its interim results for the six months ending 30 September 2015.

Key Points:

· Revenue of £610,000 in the period (six months ended 30 September 2014: £922,000);

· Loss net of revaluation of portfolio of £258,000 in the period (six months ended 30 September 2014: profit of £6,000);

· Loss, post revaluation of portfolio, of £1,039,000 (2014: £88,000);

· Good progress made on exit potential of the portfolio; and

· Continuation of reorganisation and restructuring head office.

Post period end:

· Sale of one portfolio company, Bloxx Limited, returning cash of around £164,000 to investment clients and £678,000 less contingent consideration of £262,000 to our balance sheet.

 

 

Further information:

Braveheart Investment Group plc

Trevor Brown, CEO Tel: +44 1738 587555

 

Sanlam Securities UK Limited (Nominated Advisor and Broker to Braveheart)

Lindsay Mair / James Thomas Tel: +44 20 7628 2200

 

 

Chairman and Chief Executive Officer's Statement

We are pleased to report to shareholders for the six months ended 30 September 2015.

Strategy

Since last reporting to shareholders in August 2015, we have continued to look critically at all our operating costs and have identified further areas where costs can be reduced. We are now approaching the end of this review and expect that the key result of this work will be that we can look forward to beginning the new financial year with costs and income at levels which should result in modestly profitable trading from our continuing fund management businesses.

Portfolio

Braveheart's directly held portfolio (the "Portfolio") currently represents the major proportion of shareholder funds and where there was both positive and negative news.

The negative news is that, as part of our comprehensive appraisal of operations, we have undertaken a review of the value of the constituent investments in the Portfolio and have decided it is appropriate to reduce their combined value to £1.76m. (31 March 2015 £2.48m), though this may prove to have been conservative in retrospect. We intend to step-up our efforts to pro-actively work with the managements of our portfolio companies to add value wherever possible and accelerate exits where appropriate.

More positively, on 30 October 2015, a subsidiary of Braveheart, Caledonia Portfolio Realisations Ltd (CPR), along with other investors in Bloxx Ltd which includes a number of Braveheart clients, sold its investment in Bloxx Ltd to Akamai Technologies Incorporated for an aggregate consideration of £678,000 in cash (net of costs), of which £143,000 is to be retained by the purchaser for two years. An aggregate contingent consideration of £262,000 will be settled by Braveheart in due course. In addition, the Company's investor clients will receive £164,000.

Bloxx Ltd is a web and internet filtering software business. At 31 March 2014 the abbreviated accounts of Bloxx Ltd showed net assets of £2.34m. Braveheart acquired Bloxx Ltd in April 2007 as part of the West Lothian Portfolio for which it paid £50,000, and it has since invested a further £50,000 in Bloxx Ltd. The investment in Bloxx Ltd was valued in CPR's accounts at £690,000 with a contingent consideration of £262,000. The disposal is at a premium to the amount invested by Braveheart. The proceeds will significantly increase the Company's cash reserves and will be used for general working capital.

We are working energetically to maximise the returns from the remaining investments in the Portfolio with the intention of recycling cash from any realisations into projects to enhance shareholder value.

Strathtay Ventures

We are not able to report any exits on behalf of our private clients from our portfolio companies in the first half of the year, although since the period end, as noted above, an exit was achieved from one company (Bloxx Limited) which has generated a satisfactory return to both our private client shareholders and also Braveheart plc shareholders.

In our last report we noted that we were looking at long term disposal options for the Lachesis Fund. This process continues and we remain hopeful that a satisfactory conclusion will be achieved in coming months.

Viking Fund Managers

Viking is the fund manager for the Finance Yorkshire Equity Fund www.finance-yorkshire.com (FYEF). Having completed FYEF's investment phase of £40m (into a portfolio of 46 companies) Viking is investing a further £5m of extension capital while continuing to successfully manage the FYEF portfolio. Viking is also preparing to explore opportunities to acquire further fund management mandates in 2016.

WhiteRock Capital Partners

WhiteRock Capital Partners (WCP) www.whiterockcp.co.uk is the manager of the £50m Northern Ireland Growth Loan Fund (GLF). Braveheart as equal partner with NEL Fund Managers and Clarendon Fund Managers owns one third of WCP. All GLF investments are made by way of loans, typically unsecured but with an element of profit share. Finance for the £50m Growth Loan Fund - which provides loans to established Northern Ireland SMEs seeking to access growth finance - has been provided by Invest Northern Ireland and private investor, Northern Ireland Local Government Officers' Superannuation Committee (NILGOSC). We look forward to working with our partners in WCP to further develop our business in Ireland as opportunities arise.

Financial Review

Revenue was £610,000 in the six months ended 30 September 2015 (2014: £922,000) with the reduction being mainly due to the Viking equity contract shifting from investment phase into exit phase.

The Group's direct investment portfolio comprises minority stakes in unquoted investments. There were no realisations in the six months ended 30 September 2015 and, following a further review of the valuations of this portfolio, we recorded an unrealised loss on the revaluation of these investments of £724,000 (2014: loss of £197,000) which resulted in the value of the Portfolio now being £1.76m (31 March 2015: £2.48m).

Operating costs were £868,000 (2014: £928,000).

Loss before revaluation of portfolio was £258,000 in the period (six months ended 30 September 2014: loss of £6,000).

The Group recorded a loss before taxation of £1.04m or a loss of 3.84 pence per share (2014: loss of £88,000; loss of 0.35 pence per share).

Cash balances at 30 September 2015 were £260,000 (2014: £ 376,000).

The Group continues to have a corporate banking relationship with HSBC Bank plc, from whom £500,000 facilities are available but not drawn. At 30 September 2015 net assets were £2.36m (2014: £4.06m).

Outlook

The cost base of the Group has now been significantly reduced and we expect that the last elements of this program will be completed by the end of the current financial year so that the fund management businesses can return a modest profit over the course of the new financial year. Our attention will continue to focus upon developing a new strategy for the Group and working hard with our partners to achieve improvements in shareholder value. I very much look forward to be able to report positive news to our shareholders in the months ahead

 

Jeremy H Delmar-Morgan, Chairman

Trevor E Brown, Chief Executive Officer

 

 

Condensed consolidated statement of comprehensive income FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2015

 

 

 

 

Six months ended

As restated

Six months ended

 

 

Year ended

 

 

30 September

30 September

31 March

 

 

2015

2014

2015

 

 

(unaudited)

(unaudited)

(audited)

 

Note

£'000

£'000

£'000

 

 

 

 

Revenue

 

610

922

1,864

Change in fair value of investments

4

(724)

(197)

(1,080)

Movement on contingent consideration

 

(57)

115

136

Gain on disposal of investment

 

-

-

211

Finance revenue

 

-

-

14

Total income

 

(171)

840

1,145

 

 

 

 

Employee benefits expense

 

(457)

(678)

(1,394)

Other operating costs

 

(400)

(242)

(507)

Finance costs

 

(11)

(8)

(11)

Total costs

 

(868)

(928)

(1,912)

 

 

 

 

Loss before tax

 

(1,039)

(88)

(767)

 

 

 

 

Tax

 

-

-

-

 

 

 

 

Loss for the period and total comprehensive income for the period

 

(1,039)

 

(88)

(767)

 

 

 

 

Loss attributable to:

 

 

 

Equity holders of the parent

 

(1,039)

(88)

(739)

Non-controlling interest

 

-

-

(28)

 

 

(1,039)

(88)

(767)

 

 

 

 

Basic earnings per share

 

Pence

Pence

Pence

- basic and diluted

 

(3.84)

(0.35)

(2.78)

 

 

 

 

 

 

Condensed consolidated statement of FIANCIAL POSITION FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2015

 

 

 

30 September

30 September

31 March

 

 

2015

2014

2015

 

 

(unaudited)

(unaudited)

(audited)

 

Note

£'000

£'000

£'000

ASSETS

 

 

 

Non-current assets

 

 

 

Goodwill

3

580

752

752

Investments at fair value through profit or loss

4

1,762

3,522

2,478

Investment in limited liability partnership

 

5

5

5

Other receivables

 

91

-

91

 

 

2,438

4,279

3,326

 

 

 

 

Current assets

 

 

 

 

Trade and other receivables

 

274

184

248

Cash and cash equivalents

 

260

376

502

 

 

534

560

750

 

 

 

 

Total assets

 

2,972

4,839

4,076

 

 

 

 

LIABILITIES

 

 

 

Current liabilities

 

 

 

Trade and other payables

 

(273)

(459)

(422)

Contingent consideration

5

(262)

(226)

(205)

Deferred income

 

(37)

(53)

(18)

 

 

(572)

(738)

(645)

 

 

 

 

Non-current liabilities

 

 

 

Borrowings

 

(43)

(43)

(43)

 

 

(43)

(43)

(43)

 

 

 

 

Total liabilities

 

(615)

(781)

(688)

 

 

 

Net assets

 

2,357

4,058

3,388

 

 

 

EQUITY

 

 

 

Called up share capital

 

541

541

541

Share premium 

 

1,564

1,564

1,564

Merger reserve

 

524

524

524

Retained earnings

 

(244)

1,429

787

Equity attributable to owners of the parent

2,385

4,058

3,416

Non-controlling interest

 

(28)

-

(28)

Total equity

 

2,357

4,058

3,388

 

 

Condensed consolidated statement of cash flows FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2015

 

 

 

Six months ended

 

As restated

Six months ended

 

 

 

Year ended

 

30 September

30 September

31 March

 

2015

2014

2015

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Operating activities

 

 

(Loss) before tax

(1,039)

(88)

(767)

 

 

 

Adjustments to reconcile (loss) before tax to net cash flows from operating activities

 

 

Share-based payments expense

8

3

12

Impairment losses

172

 

 

Decrease in the fair value movements of investments

724

197

1,080

Gain on disposal of equity investments

-

-

(211)

Interest income

-

-

(14)

Decrease/(increase) in trade and other receivables

(26)

327

172

(Decrease)/increase in trade and other payables

(73)

(359)

(452)

Net cash flow from operating activities

(234)

80

(180)

 

 

 

Investing activities

 

 

Proceeds from sale of subsidiary

-

-

415

Increase in investments

(17)

-

(60)

Repayment of loan notes

9

6

23

Interest received

-

-

14

Net cash flow from investing activities

(8)

6

392

 

 

 

Financing activities

 

 

Proceeds from issue of share capital

-

131

131

Net cash flow from financing activities

-

131

131

 

 

 

Net (decrease)/ increase in cash and cash equivalents

(242)

217

343

Cash and cash equivalents at the start of the period

502

159

159

Cash and cash equivalents at the end of the period

260

376

502

 

 

 

 

 

 

Condensed consolidated statement of changes in equity FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2015

Attributable to owners of the Parent

 

Share Capital

Share Premium

Merger Reserve

Retained Earnings

Total

Non-controlling Interest

Total Equity

£'000

£'000

£'000

£'000

£'000

£'000

£'000

At 1 April 2014 (audited)

517

1,457

524

1,514

4,012

-

4,012

Issue of new share capital

24

107

-

-

131

-

131

Share-based payments

-

-

-

3

3

-

3

Transactions with owners

24

107

-

3

134

-

134

Loss and total comprehensive income for the period

-

-

-

(88)

(88)

-

(88)

At 30 September 2014 (unaudited)

541

1,564

524

1,429

4,058

-

4,058

Share-based payments

-

-

-

9

9

-

9

Transactions with owners

-

-

-

9

9

-

9

Loss and total comprehensive income for the period

-

-

-

(651)

(651)

(28)

(679)

At 1 April 2015 (audited)

541

1,564

524

787

3,416

(28)

3,388

Share-based payments

-

-

-

8

8

-

8

Transactions with owners

-

-

-

8

8

-

8

Loss and total comprehensive income for the period

-

-

-

(1,039)

(1,039)

-

(1,039)

At 30 September 2015 (unaudited)

541

1,564

524

(244)

2,385

(28)

2,357

 

 

 

 

 

NOTES TO THE INTERIM FINANCIAL STATEMENTS

 

1 Basis of preparation

The financial information presented in this half-yearly report constitutes the condensed consolidated financial statements (the interim financial statements) of Braveheart Investment Group plc (Braveheart or the Company), a company incorporated in the United Kingdom and registered in Scotland, and its subsidiaries (together, the Group) for the six months ended 30 September 2015. The interim financial statements have been prepared in accordance with IAS 34 Interim Financial Reporting and should be read in conjunction with the Annual Report and Accounts for the year ended 31 March 2015 which have been prepared in accordance with International Financial Reporting Standards as adopted for use in the EU. The financial information in this half-yearly report, which was approved by the Board and authorised for issue on 2 November 2015 is unaudited.

The interim financial statements do not constitute statutory accounts for the purpose of sections 434 and 435 of the Companies Act 2006. The comparative financial information presented herein for the year ended 31 March 2015 has been extracted from the Group's Annual Report and Accounts for the year ended 31 March 2015 which have been delivered to the Registrar of Companies. The Group's independent auditors' report on those accounts was unqualified, did not include references to any matters to which the auditors drew attention by way of emphasis without qualifying their report and did not contain a statement under section 498(2) or 498(3) of the Companies Act 2006.

The preparation of the half-yearly report requires management to make judgements, estimates and assumptions that affect the policies and the reported amounts of assets and liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making judgements about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. In preparing this half-yearly report, the significant judgements made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were the same as those applied to the audited consolidated financial statements for the year ended 31 March 2015.

The interim financial statements have been prepared using the same accounting policies as those applied by the Group in its audited consolidated financial statements for the year ended 31 March 2015 and which will form the basis of the 2016 Annual Report. The interim financial statements have been prepared on the same basis as the financial statements for year ended 31 March 2015 which is on the assumption that the company is a going concern.

 

2 Earnings per share

The basic earnings per share has been calculated by dividing the loss for the period attributable to equity holders of the parent by the weighted average number of ordinary shares in issue during the period.

The calculation of earnings per share is based on the following (loss)/profit and number of shares in issue:

 

Six months ended

Year ended

 

30 September

31 March

 

2015

2014

2015

 

£'000

£'000

£'000

 

 

 

Loss for the period attributable to equity holders of the parent

(1,039)

(88)

(739)

 

 

 

Weighted average number of ordinary shares in issue:

 

 

- For basic loss per ordinary share

27,055,491

24,839,559

26,626,973

- For diluted loss per ordinary share

27,055,491

24,839,559

26,626,973

 

3 Goodwill

VFM

Neon

Total

£'000

£'000

£'000

At 1 April 2014 (audited)

372

380

752

At 30 September 2014 (unaudited)

372

380

752

At 31 March 2015 (audited)

372

380

752

Movement

(172)

-

(172)

At 30 September 2015 (unaudited)

200

380

580

 

The Group assessed the recoverable amount of the above goodwill with each of Viking and Neon's cash generating units and determined that Viking's goodwill was impaired. The recoverable amount was assessed by reference to the cash generating unit's value in use based on internally prepared and approved 3 year cash flow projections and growth based projections for a further two years assuming a 2.5% growth rate and 12.5% discount factor.

 

4 Investments at fair value through profit or loss

Level 1

Level 2

Level 3

Equity investments in quoted companies

Equity investments in unquoted companies

Debt investments in unquoted companies

Equity investments in unquoted companies

Debt investments in unquoted companies

Total

£'000

£'000

£'000

£'000

£'000

£'000

At 1 April 2014 (audited)

-

-

-

3,601

124

3,725

Repayments

-

-

-

-

(6)

(6)

Change in Fair Value

-

-

-

(197)

-

(197)

At 30 September 2014 (unaudited)

-

-

-

3,404

118

3,522

Repayments/disposals

-

-

-

(203)

(18)

(221)

Additions at Cost

-

-

-

-

60

60

Change in Fair Value

-

-

-

(883)

-

(883)

At 1 April 2015 (audited)

-

-

-

2,318

160

2,478

Repayments

-

-

-

-

(9)

(9)

Additions at cost

-

-

-

-

17

17

Change in Fair Value

 

 

 

(714)

(10)

(724)

At 30 September 2015

(unaudited)

-

-

-

1,604

158

1,762

 

All unquoted investments have been classified as Level 3 within the fair value hierarchy, their respective valuations having been calculated using a number of valuation techniques and assumptions, notwithstanding that the basis of the valuation methodology used most commonly by the Group is 'price of most recent investment'. The use of reasonably possible alternative assumptions has no material effect on the fair valuation of the related investments. The impact on the fair value of investments if the discount rate and provision shift by 1% is £11,508 (2014: £15,946).

 

5 Contingent consideration

During the half year, £57,000 was debited (half year to September 2014: credited £115,000) to the statement of comprehensive income in respect of the increase in the sum due on future exit values of the Caledonia Portfolio Realisations (CPR) portfolio as a result of an increase in the fair value of the related portfolio assets. The contingent consideration will be eliminated once the sale of Bloxx Limited is recorded in the accounts.

6 Share capital

The Company has one class of ordinary shares. All shares carry equal voting rights, equal rights to income and distribution of assets on liquidation or otherwise, and no right to fixed income. 

7 Post balance sheet events

We completed the sale of our investment in Bloxx Limited.

A copy of this report is available on request from the Company's registered office: 2 Dundee Road, Perth, PH2 7DW. A copy has also been posted on the Company's website: www.braveheartinvestmentgroup.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR EALFAEAXSFFF
Date   Source Headline
29th Apr 20242:07 pmRNSHolding(s) in Company
29th Apr 20241:42 pmRNSBlock admission six monthly return
10th Apr 20247:00 amRNSHolding(s) in Company
27th Mar 202412:03 pmRNSHolding(s) in Company
6th Mar 20247:00 amRNSAcquisition of further interest in Autins Group
4th Mar 202411:48 amRNSInvestment update – Paraytec Limited
4th Mar 20247:00 amRNSCompletion of sale of Phasefocus
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
22nd Dec 20237:00 amRNSPortfolio update - Proposed sale of Phasefocus
15th Dec 202311:41 amRNSInvestment update - Paraytec Limited
15th Dec 202310:16 amRNSReplacement: Half-year Report
14th Dec 20237:00 amRNSHalf-year Report
29th Nov 20237:00 amRNSInvestment update - Paraytec Limited
14th Nov 20239:02 amRNSHolding(s) in Company
17th Oct 20237:00 amRNSInvestment update – Paraytec Limited
10th Oct 202311:15 amRNSHolding(s) in Company
8th Sep 20237:00 amRNSInvestment update – Kirkstall Limited
8th Sep 20237:00 amRNSBlock admission six monthly return
21st Aug 20237:00 amRNSFurther investment in Phasefocus Holdings Limited
28th Jul 20232:25 pmRNSInvestment update on Paraytec Limited
28th Jul 202311:54 amRNSResult of AGM
5th Jul 20237:00 amRNSPosting of annual report and notice of AGM
4th Jul 20237:00 amRNSHolding(s) in Company
3rd Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
31st May 20237:00 amRNSInvestment update – Phasefocus Holdings Limited
3rd May 20237:00 amRNSUpdate on investments
24th Apr 202310:49 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSGrant of options
13th Mar 20239:34 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSBlock admission six monthly return
10th Feb 20231:26 pmRNSHolding(s) in Company
30th Jan 20234:37 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSOperational update
22nd Dec 20229:14 amRNSHolding(s) in Company
19th Dec 20229:25 amRNSDirector/PDMR Shareholding
19th Dec 20229:11 amRNSAcquisition of interest in Image Scan Holdings plc
13th Dec 20224:37 pmRNSHolding(s) in Company
15th Nov 20223:09 pmRNSHolding(s) in Company
7th Nov 20227:00 amRNSDirector/PDMR Shareholding
28th Oct 20227:00 amRNSHalf-year Report
21st Oct 202210:33 amRNSHolding(s) in Company
20th Oct 20221:59 pmRNSAcquisition of further interest in Autins
5th Oct 20223:15 pmRNSHolding(s) in Company
5th Oct 202212:28 pmRNSAcquisition of further interest in Aukett Swanke
30th Sep 20225:00 pmRNSTotal Voting Rights
20th Sep 20227:00 amRNSPlacing and subscription to raise £750,000
9th Sep 20227:00 amRNSBlock admission six monthly return
6th Sep 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.